Search PubMed⌕ Search

PubMed · 8372963

Development and evaluation of an error-compensating predictive data-processing method for liquid chromatography.

Abstract

This paper describes an alternative data-processing approach for liquid chromatographic responses. Transient data from the leading edges of chromatographic peaks for nonsaturating amounts of sample are used with a suitable mathematical model and curve-fitting program to predict the steady-state response that would be measured if sufficient sample were used to saturate the system. Results obtained by this approach are compared with peak-height and peak-area options by using aspirin as an analyte. For aspirin concentrations from 0.6 to 5.0mmol/L, each data-processing option yields linear calibration plots for each of several sample volumes from 50 to 100 microL and flow rates from 1.0 to 3.0 mL/min. As expected, the predictive option yielded lower dependency on sample volume (20-30-fold improvement) and flow rate (10-fold improvement) than the peak-height and peak-area options. However, the peak-height option provided slightly better (approximately 2-fold) calibration statistics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Li, H L Pardue. 1993-08-01. Development and evaluation of an error-compensating predictive data-processing method for liquid chromatography.. https://doi.org/10.1021/ac00063a009

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

LC-MS-MS determination of nemorubicin (methoxymorpholinyldoxorubicin, PNU-152243A) and its 13-OH metabolite (PNU-155051A) in human plasma.

A selective and sensitive liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for quantitative determination of nemorubicin, (PNU-152243A, 3'-deamino-3'[2(S)-methoxy-4-morpholinyl]doxorubicin) hydrocloride and its reduced metabolite PNU-155051 in human plasma has been developed and validated. The method involved solid phase extraction (SPE) in 96-well plates. Plasma samples (0.5 ml plasma, spiked with doxorubicin as internal standard and diluted with 0.5 ml of 0.01 M borate buffer, pH 8.4) were extracted using Oasis HLB SPE material. The elution of PNU-152243, PNU-155051 and of IS was performed with 1 ml of methanol:0.1 M formic acid mixture (90:10, v/v). The organic phase was reduced to dryness under a stream of nitrogen at 20 degrees C and the residue was reconstituted with 0.25 ml of 10 mM ammonium formate buffer pH 4.15:acetonitrile mixture (90:10, v/v). Aliquots of 60 microl of the resulting solution were injected onto the LC-MS-MS system. A Zorbax SB C18 column (2.1 x 150 mm, 3.5 microm) was used to perform the chromatographic analysis. The mobile phase consisted of ammonium formate buffer 10 mM pH 4.15:acetonitrile (73:27, v/v) with a flow-rate of 0.2 ml/min. Detection was achieved by a PE-SCIEX API 3000 with Turbo IonSpray interface, and multiple reaction monitoring (645 --> 321 for PNU-152243, 647 --> 363 for PNU-155051 and 545 --> 345 m/z for doxorubicin) operated in positive ion mode. A weighted linear regression was used to calculate PNU-152243 and PNU-155051 concentrations in QC and unknown samples. Linearity, precision, accuracy and recovery of the method were evaluated over the concentration range of 0.1-5 ng/ml for both compounds. No interference from blank human plasma was observed. The suitability of the method for in vivo samples was assessed by the analysis of samples obtained from patients who had received a single intrahepatic artery dose of PNU-152243A.

Chromatography, Liquid↗

Liquid chromatographic determination of fluoxetine.

A simple, accurate and sensitive high pressure liquid chromatographic technique is described for the determination of fluoxetine in the capsule dosage form, human plasma and in biological fluid. Analysis is performed with a reversed phase-C18 column with ultraviolet detection at 228 nm. The isocratic mobile phase (1.5 ml/min.) consists of acetonitrile and triethylamine buffer (48 + 52, V/V). A linear calibration model (correlation coefficient 0.99863) was developed using pyridoxine as internal standard. The retention times were 2.10 and 3.20 min for pyridoxine and fluoxetine, respectively. The method was applied for the quantitation of fluoxetine in spiked human plasma samples. The detection limit is 5 microg/l and the absorbance varies with fluoxetine concentrations in the range (10-300) microg/l. The mean % recovery +/- S.D. was found to be 97.99% +/- 2.39. The proposed method was applied successfully for monitoring of fluoxetine in human plasma after single dose administration of one prozac capsule.

Chromatography, Liquid↗

Determining the vinyl alcohol distribution in poly(vinyl butyral) using normal-phase gradient polymer elution chromatography.

The vinyl alcohol (VOH) functionality in poly(vinyl butyral) is known to be responsible for a number of important end-use properties, such as controlling adhesion to surfaces, influencing cross-linking behavior, etc. In order to determine the distribution of the VOH percentage in PVB, with the associated averages and polydispersity, we have developed a normal-phase gradient polymer elution chromatography (NP-GPEC) method which relies on both precipitation-redissolution as well as on sorptive interactions between the polymer and the column packing. The method is shown to operate in the linear region of detector response with respect to key operational parameters and is demonstrated to be independent of chemical composition distribution, molar mass, or polydispersity in either molar mass or VOH content. Several examples are given, including where NP-GPEC readily allows visualization of differences between samples that appear identical when analyzed by standard methods.

Chromatography, Liquid↗